Andrea Llano

578 total citations
20 papers, 171 citations indexed

About

Andrea Llano is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Andrea Llano has authored 20 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Andrea Llano's work include Diabetes Treatment and Management (7 papers), Pancreatic function and diabetes (4 papers) and Diabetes Management and Research (3 papers). Andrea Llano is often cited by papers focused on Diabetes Treatment and Management (7 papers), Pancreatic function and diabetes (4 papers) and Diabetes Management and Research (3 papers). Andrea Llano collaborates with scholars based in United Kingdom, Italy and Colombia. Andrea Llano's co-authors include Edward T. Wargent, Neil Pearce, Matthew P. Coghlan, Julie C. Holder, Carolyn A. Lister, John Yates, Stephen A. Smith, Gregory Murphy, Alejandro Abuin and Jonathan R.S. Arch and has published in prestigious journals such as Hypertension, British Journal of Pharmacology and Metabolism.

In The Last Decade

Andrea Llano

18 papers receiving 166 citations

Peers

Andrea Llano
Daniel Fineberg Australia
Yusof Rahman United Kingdom
May E. Montasser United States
Alexander M. Roche United States
Andrea Llano
Citations per year, relative to Andrea Llano Andrea Llano (= 1×) peers Jaroslava Trnovská

Countries citing papers authored by Andrea Llano

Since Specialization
Citations

This map shows the geographic impact of Andrea Llano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Llano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Llano more than expected).

Fields of papers citing papers by Andrea Llano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Llano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Llano. The network helps show where Andrea Llano may publish in the future.

Co-authorship network of co-authors of Andrea Llano

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Llano. A scholar is included among the top collaborators of Andrea Llano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Llano. Andrea Llano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCallum, Linsay, Stefanie Lip, Alex McConnachie, et al.. (2024). UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide. Hypertension. 81(10). 2049–2059. 10 indexed citations
2.
Morrison, Deborah, et al.. (2023). Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes. Diabetes Therapy. 14(5). 937–945. 16 indexed citations
3.
Llano, Andrea, et al.. (2023). Atorvastatin. Practical Diabetes. 40(2). 42–42. 1 indexed citations
4.
Llano, Andrea, et al.. (2023). Gastric disorders: modifications of gastric content, antacids and drugs influencing gastric secretions and motility. Anaesthesia & intensive care medicine. 24(9). 531–535.
5.
Llano, Andrea, et al.. (2022). Amiloride. Practical Diabetes. 39(2). 41–43. 1 indexed citations
6.
Llano, Andrea, et al.. (2022). Drugs used in the management of hyperglycaemia. Anaesthesia & intensive care medicine. 24(1). 78–81. 1 indexed citations
7.
Llano, Andrea, et al.. (2021). Abstracts of the 7 th Congress of the European Academy of Neurology, Virtual 2021.. European Journal of Neurology. 1–921. 2 indexed citations
8.
Llano, Andrea, et al.. (2021). Inclisiran. Practical Diabetes. 38(2). 41–43. 1 indexed citations
9.
Llano, Andrea, et al.. (2020). Pramlintide. Practical Diabetes. 37(5). 194–195. 2 indexed citations
10.
Llano, Andrea & Gerard McKay. (2020). Non-insulin therapies in addition to insulin in Type 1 DM treatment. British Medical Bulletin. 134(1). 54–62. 3 indexed citations
11.
Llano, Andrea, et al.. (2020). Bevacizumab. Practical Diabetes. 37(2). 70–71. 2 indexed citations
12.
Llano, Andrea, et al.. (2020). Topiramate. Practical Diabetes. 37(1). 34–34. 1 indexed citations
13.
Llano, Andrea, et al.. (2019). SGLT inhibitors for people with type 1 diabetes. Practical Diabetes. 36(3). 91–96. 7 indexed citations
14.
Llano, Andrea, et al.. (2018). The treatment of type 2 diabetes in heart failure. Practical Diabetes. 35(4). 123–126. 3 indexed citations
15.
Llano, Andrea, et al.. (2018). A18709 Mendelian Randomization study of causal relationship of height on blood pressure and arterial stiffness. Journal of Hypertension. 36. e91–e92. 3 indexed citations
16.
Llano, Andrea, et al.. (2017). Biosimilar insulin: the current landscape. Practical Diabetes. 34(2). 51–54. 3 indexed citations
17.
Llano, Andrea, et al.. (2016). Drug development and licensing in diabetes. Practical Diabetes. 33(2). 60–64.
18.
Pearce, Neil, Jonathan R.S. Arch, John C. Clapham, et al.. (2004). Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter. Metabolism. 53(10). 1322–1330. 90 indexed citations
19.
Wilson, William S., et al.. (2003). Evaluation of potassium ion as the endothelium‐derived hyperpolarizing factor (EDHF) in the bovine coronary artery. British Journal of Pharmacology. 139(5). 982–988. 23 indexed citations
20.
Llano, Andrea. (2000). Medical ethics education in Colombia.. PubMed. 19(3). 415–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026